🦴

Ehlers-Danlos Syndromes Overview and Features

Apr 17, 2025

Understanding Ehlers-Danlos Syndromes (EDS)

Overview of EDS

  • EDS are a group of 13 heritable connective tissue disorders caused by genetic changes affecting connective tissue.
  • Common features across all EDS types:
    • Joint hypermobility
    • Skin hyperextensibility
    • Tissue fragility

Key Features of EDS

Joint Hypermobility

  • Defined as joints having a greater range of motion than usual.
  • Can lead to joint instability, subluxations, dislocations, sprains, and injuries.
  • Can be widespread or localized to certain areas like hands and feet.

Skin Hyperextensibility

  • Skin stretches beyond the normal range, measured on the forearm.
  • Severe hyperextensibility (>2 cm) in certain EDS types.
  • Other skin issues: unusual texture, fragility, thinness, delayed healing, abnormal scarring.

Tissue Fragility

  • Increased vulnerability to damage, easy bruising, poor wound healing.
  • Severe fragility in skin, blood vessels, organs, eyes, gums, bones in some EDS types.

Types of EDS

  • 13 types, each with unique genetic causes and features.
  • Common Types:
    • Hypermobile EDS (hEDS): Most common, characterized by joint hypermobility.
    • Classical EDS (cEDS): Characterized by skin fragility and hyperextensibility.
    • Vascular EDS (vEDS): Characterized by arterial fragility.
  • Ultra-Rare Types: Arthrochalasia, Dermatosparaxis, Kyphoscoliotic, etc., each affecting less than 1 in a million.

Prevalence of EDS

  • hEDS affects 1 in 3,100-5,000 people.
  • cEDS affects 1 in 20,000-40,000 people.
  • vEDS affects 1 in 100,000-200,000 people.
  • Other types are ultra-rare, affecting fewer than 1 in 1 million people.

Genetic Causes and Inheritance

  • Variants in genes affecting collagen and connective tissues cause EDS.
  • Inheritance patterns:
    • Dominant: One copy of the variant needed (50% chance of passing to children).
    • Recessive: Two copies needed (from each parent).

Diagnosis and Management

  • Diagnosis involves clinical criteria and genetic testing (except for hEDS).
  • No disease-specific treatments; management is symptom-based and often involves multiple specialists.

Historical Context

  • Named after Dr. Edvard Ehlers and Dr. Henri-Alexandre Danlos.
  • Classification evolved from Roman numeral system to descriptive names.
  • Current classification includes 13 types and hypermobility spectrum disorders (HSD).

Research and Future Directions

  • Ongoing research may lead to new classifications and understanding of EDS.
  • New genetic variants being identified that may redefine current EDS types.

Additional Information

  • EDS can be associated with other medical conditions like dysautonomia and mast cell diseases.
  • Management plans are individualized based on symptoms and responses to treatment.

This summary provides a high-level overview of Ehlers-Danlos Syndromes for educational purposes and should be supplemented with more detailed resources and consultation with healthcare professionals.